Results 131 to 140 of about 47,104 (255)
Beyond abstinence: Redefining success in cannabis use disorder treatment
Addiction, EarlyView.Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin +3 more
wiley +1 more source
A Case Report of Gabapentin-induced Psychotic Disorder
Journal of Mazandaran University of Medical Sciences, 2018 Gabapentin was first approved for treatment of epilepsy by FDA, but later it received more attention due to its effects on pain relief, especially neuropathic pain and post-herpetic neuralgia, and in treatment of anxiety and insomnia.
Pezhman Hadinezhad, Hamzeh Hosseini
doaj
Gabapentin and pregabalin exposures reported to United States poison centers, 2012–2022
Injury EpidemiologyBackground Gabapentin and pregabalin were originally introduced as anticonvulsant medications but are now also prescribed on- and off-label for multiple medical disorders, especially for pain management.
Emily J.R. Carter +7 more
doaj +1 more source
, 2008 Gabapentin is used as an analgesic in neuropathic pain. In this report a children with nerophatic pain because of mercury poising was followed-up for pain and side effects with the use of gabapentin.
Reisli R., Tuncer S., Dayio?lu M.
core
Clinicians' and people who use drugs' perspectives on artificial intelligence in addiction medicine
Addiction, EarlyView.Abstract Background and aims Artificial intelligence (AI) may improve addiction medicine workflows and health outcomes but raises questions about data privacy and unintended harms for people who use drugs (PWUD). This qualitative study aimed to understand the perspectives of clinicians and PWUD regarding perceived benefits and concerns about clinical ...
Patrick J. A. Kelly +6 more
wiley +1 more source
Neuropsychiatric sequelae of chronic nitrous oxide misuse in middle‐aged adults: A case series
The American Journal on Addictions, EarlyView.Abstract Background and Objectives Chronic nitrous oxide (N2O) misuse causes heterogeneous neuropsychiatric toxicity. Methods We retrospectively reviewed three middle‐aged adults with chronic N2O misuse and neuropsychiatric presentations. Results Presentations included cognitive impairment, hallucinations, and variable neurologic dysfunction ...
Theodore Tsonis +3 more
wiley +1 more source
Anaesthesia, EarlyView.Summary Introduction Chronic postsurgical pain after caesarean delivery is an important cause of postpartum morbidity, yet its impact on maternal quality of life has not been comprehensively synthesised. The aims of this systematic review were to evaluate the impact of chronic postsurgical pain on quality of life, including possible temporal changes in
Samira Alwahabi +6 more
wiley +1 more source
Gabapentin Discriminative Stimulus Effects
Gabapentin (Neurontin®), an anticonvulsant drug, is primarily prescribed for neuropathic pain and epileptic seizures. Gabapentin is an inhibitor of the voltage gated calcium channel (VGCC) subunit α2δ-1.
Donar, Andrew
core
Canine desexing attitudes and practices of Australian veterinarians: A cross‐sectional survey
Australian Veterinary Journal, EarlyView.Canine desexing is one of the most common small animal surgical procedures in Australia, yet little is known about current practices. This study characterised attitudes, practitioner recommendations and surgical practices for routine canine desexing among Australian veterinarians using an online cross‐sectional survey (n = 107). Respondent demographics
S. Impey +4 more
wiley +1 more source
Novel approaches for drug development against chronic primary pain: A systematic review
British Journal of Pharmacology, EarlyView.Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus +5 more
wiley +1 more source